BIORCHESTRA
VerifiedDeveloping novel rna-based therapeutics for neuroinflammatory diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$180—270m (Dealroom.co estimates Feb 2022.)
Cambridge Massachusetts (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
* | $45.0m | Series C | |
| Total Funding | 000k | ||